Hippocratic AI has raised $126 million in a Series C funding round led by Avenir Growth, valuing the company at $3.5 billion and bringing its total funding to $404 million. The investment included participation from CapitalG, Andreessen Horowitz, General Catalyst, Kleiner Perkins, and other investors. In just over a year since commercialization, the company has partnered with more than 50 healthcare organizations across six countries and completed over 115 million patient interactions without any safety issues. Avenir Growth Co-Founder Andrew Sugrue said Hippocratic AI’s strong focus on safety has earned the trust of healthcare executives worldwide.
CEO and Co-founder Munjal Shah stated, “After speaking with a significant number of customers before investing, we believe Hippocratic AI is leading the agentic healthcare category. Importantly, we found that their relentless focus on safety has earned them the trust of healthcare organizations around the world, becoming the safe choice for executives when choosing AI agents for deployment in healthcare.” Julie Yoo, General Partner at Andreessen Horowitz, highlighted, “Their rapid growth is a testament to the demand for solutions to our industry’s labor and patient access crisis, and the unique capabilities that Hippocratic has brought to market to address those needs.”
